Low- and high-grade bladder cancer determination via human serum-based metabolomics approach

Journal of Proteome Research

Volumn 12, Issue 12, 2013, Pages 5839-5850

  Bansal, Navneeta ^a   Gupta, Ashish ^b   Mitash, Nilay ^b   Shakya, Prashant Singh ^b   Mandhani, Anil ^b   Mahdi, Abbas Ali ^a   Sankhwar, Satya Narain ^a   Mandal, Sudhir Kumar ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

NMR spectroscopy; serum metabolomics; Urinary bladder cancer

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; METABOLOMICS; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SERUM; VALIDATION STUDY; ADULT; BLOOD; CASE CONTROL STUDY; CYSTOSCOPY; DISCRIMINANT ANALYSIS; DOUBLE BLIND PROCEDURE; MALE; METABOLOME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; URINARY BLADDER NEOPLASMS;

TUMOR MARKER;

ADULT; CASE-CONTROL STUDIES; CYSTOSCOPY; DISCRIMINANT ANALYSIS; DOUBLE-BLIND METHOD; HUMANS; LEAST-SQUARES ANALYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOME; MIDDLE AGED; NEOPLASM GRADING; ROC CURVE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84890022346     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr400859w     Document Type: Article

References (68)

1. Siegel, R.; Ward, E.; Brawley, O.; Jemal, A. Cancer statistics 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA-Cancer J. Clin. 2011, 61, 212-236
2. Kitamura, H.; Tsukamoto, T. Early bladder cancer: Concept, diagnosis, and management Int. J. Clin. Oncol. 2006, 11, 28-37
3. Mitra, A. P.; Cote, R. J. Molecular screening for bladder cancer: Progress and potential Nat. Rev. Urol. 2010, 7, 11-20
4. Schroeder, G. L.; Lorenzo-Gomez, M. F.; Hautmann, S. H.; Friedrich, M. G.; Ekici, S.; Huland, H.; Lokeshwar, V. A side by side comparison of cytology and biomarkers for bladder cancer detection J. Urol. 2004, 172, 1123-1126
5. Botteman, M. F.; Pashos, C. L.; Redaelli, A.; Laskin, B.; Hauser, R. The health economics of bladder cancer: A comprehensive review of the published literature PharmacoEconomics 2003, 21, 1315-1330
6. Messing, E. M.; Young, T. B.; Hunt, V. B.; Gilchrist, K. W.; Newton, M. A.; Bram, L. L.; Hisgen, W. J.; Greenberg, E. B.; Kuglitsch, M. E.; Wegenke, J. D. Comparison of bladder cancer outcome in men undergoing hematuria home screening vs. those with standard clinical presentations Urology 1995, 45, 387-396
7. Sciarra, A.; De Matteis, A.; Mariotti, G.; Voria, G.; Lucera, R.; Di Silverio, F. Histopathologic aspects of transitional cell carcinoma of the bladder: Analysis of 20 years experience Int. J. Urol. 2004, 11, 467-475
8. Glatz, K.; Willi, N.; Glatz, D.; Barascud, A.; Grilli, B.; Herzog, M.; Dalquen, P.; Feichter, G.; Gasser, T. C.; Sulser, T.; Bubendorf, L. An international telecytologic quiz on urinary cytology reveals educational deficits and absence of a commonly used classification system Am. J. Clin. Pathol. 2006, 126, 294-301
9. Leyh, H.; Marberger, M.; Conort, P.; Sternberg, C.; Pansadoro, V.; Pagano, F.; Bassi, P.; Boccon-Gibod, L.; Ravery, V.; Treiber, U.; Ishak, L. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer Eur. Urol. 1999, 35, 52-56
10. Planz, B.; Jochims, E.; Deix, T.; Caspers, H. P.; Jakse, G.; Boecking, A. The role of urinary cytology for detection of bladder cancer Eur. J. Surg. Oncol. 2005, 31, 304-308
11. Knowles, M. A. Molecular pathogenesis of bladder cancer Int. J. Clin. Oncol. 2008, 13, 287-297
12. Lacy, S.; Lopez-Beltran, A.; MacLennan, G. T.; Foster, S. R.; Montironi, R.; Cheng, L. Molecular pathogenesis of urothelial carcinoma: The clinical utility of emerging new biomarkers and future molecular classification of bladder cancer Anal. Quant. Cytol. Histol. 2009, 31, 5-16
13. Lintula, S.; Hotakainen, K. Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer Expert Opin. Biol. Ther. 2010, 1169-1180
14. Bryan, R. T.; Zeegers, M. P.; James, N. D.; Wallace, D. M.; Cheng, K. K. Biomarkers in bladder cancer BJU Int. 2009, 105, 608-613
15. Shariat, S. F.; Zippe, C.; Ludecke, G.; Boman, H.; Sanchez-Carbayo, M.; Casella, R. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder J. Urol. 2005, 173, 1518-1525
16. Lotan, Y.; Elias, K.; Svatek, R. S.; Bagrodia, A.; Nuss, G.; Moran, B.; Sagalowsky, A. I. Bladder cancer screening in a high risk asymptomatic population using a point of care urine based protein tumor marker J. Urol. 2009, 182, 52-57
17. Mitra, A. P.; Datar, R. H.; Cote, R. J. Molecular pathways in invasive bladder cancer: New insights into mechanisms, progression, and target identification J. Clin. Oncol. 2006, 24, 5552-5564
18. Spratlin, J. L.; Serkova, N. J.; Eckhardt, S. G. Clinical applications of metabolomics in oncology: A review Clin. Cancer Res. 2009, 15, 431-440
19. Lewis, G. D.; Wei, R.; Liu, E.; Yang, E.; Shi, X.; Martinovic, M. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury J. Clin. Invest. 2008, 118, 3503-3512
20. Gupta, A.; Bansal, N.; Houston, B. Metabolomics of urinary tract infection: A new uroscope in town Expert Rev. Mol. Diagn. 2012, 12, 361-369
21. 1H NMR spectroscopy J. Proteome Res. 2012, 11, 1844-1854
22. Sreekumar, A.; Poisson, L. M.; Rajendiran, T. M.; Khan, A. P.; Cao, Q.; Yu, J. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 2009, 457, 910-914
23. Thysell, E.; Surowiec, I.; Hornberg, E.; Crnalic, S.; Widmark, A.; Johansson, A. I.; Stattin, P.; Bergh, A.; Moritz, T.; Antti, H.; Wikstrom, P. Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol PLoS One 2010, 5, e14175-1-e14175-10
24. Asiago, V. M.; Alvarado, L. Z.; Shanaiah, N.; Gowda, G. A.; Owusu-Sarfo, K.; Ballas, R. A.; Raftery, D. Early detection of recurrent breast cancer using metabolite profiling Cancer Res. 2010, 70, 8309-8318
25. Zhang, J.; Liu, L.; Wei, S.; Nagana Gowda, G. A.; Hammoud, Z.; Kesler, K. A.; Raftery, D. Metabolomics study of esophageal adenocarcinoma J. Thorac. Cardiovasc. Surg. 2011, 141, 469-475
26. Issaq, H. J.; Nativ, O.; Waybright, T.; Luke, B.; Veenstra, T. D.; Issaq, E. J.; Kravstov, A.; Mullerad, M. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry J. Urol. 2008, 179, 2422-2426
27. Huang, Z.; Lin, L.; Gao, Y.; Chen, Y.; Yan, X.; Xing, J.; Hang, W. Bladder cancer determination via two urinary metabolites: A biomarker pattern approach Mol. Cell. Proteomics 2011, 10, 1-10
28. Pasikanti, K. K.; Esuvaranathan, K.; Ho, P. C.; Mahendran, R.; Kamaraj, R.; Wu, Q. H.; Chiong, E.; Chan, E. C. Y. Noninvasive urinary metabonomic diagnosis of human bladder cancer J. Proteome Res. 2010, 9, 2988-2995
29. 1H NMR spectroscopy Cancer Biomarkers 2010, 6, 11-20
30. Zhang, J.; Wei, S.; Liu, L.; Nagana Gowda, G. A.; Bonney, P.; Stewart, J.; Knapp, D. W.; Raftery, D. NMR-based metabolomics study of canine bladder cancer Biochim. Biophys. Acta 2012, 1822, 1807-1814
31. Walsh, M. C.; Brennan, L.; Malthouse, J. P. G.; Roche, H. M.; Gibney, M. J. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans Am. J. Clin. Nutr. 2006, 84, 531-539
32. 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects J. Pharm. Biomed. Anal. 2004, 36, 841-849
33. Vigneau-Callahan, K. E.; Shestopalov, A. I.; Milbury, P. E.; Matson, W. R.; Kristal, B. S. Characterization of diet-dependent metabolic serotypes: Analytical and biological variability issues in rats J. Nutr. 2001, 131, 924S-932S
34. Cao, M.; Zhao, L.; Haigo, C.; Xue, W.; Lin, D. NMR-based metabolomics analysis of human bladder cancer Anal. Sci 2012, 28, 451-456
35. Weiss, R. G.; Gerstenblith, G.; Bottomley, P. A. ATP Flux through creatine kinase in the normal, stressed and failing human heart Proc. Natl. Acad. Sci. U.S.A. 2005, 1002, 808-813
36. Gupta, A.; Chacko, V. P.; Weiss, R. G. Abnormal energetics and ATP depletion in pressure-overload mouse hearts: In vivo high-energy phosphate concentration measures by noninvasive magnetic resonance Am. J. Physiol.: Heart Circ. Physiol. 2009, 297, H59-H64
37. Gupta, A.; Chacko, V. P.; Schär, M.; Akki, A.; Weiss, R. G. Impaired ATP kinetics in failing in vivo mouse heart Circ. Cardiovasc. Imaging 2011, 42-50
38. Gupta, A.; Akki, A.; Wang, Y.; Leppo, M. K.; Chacko, V. P.; Foster, D. B. Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved J. Clin. Invest. 2012, 122, 291-302
39. Epstein, J. I.; Amin, M. B.; Reuter, V. R.; Mostofi, F. K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am. J. Surg. Pathol. 1998, 22, 1435-1448
40. Warrack, B. M.; Hnatyshyn, S.; Ott, K. H.; Reily, M. D.; Sanders, M.; Zhang, H.; Drexler, D. M. Normalization strategies for metabonomics analysis of urine samples J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2009, 877, 547-552
41. van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genomics 2006, 7, 142-1-142-15
42. Bylesjo, M.; Eriksson, D.; Kusano, M.; Moritz, T.; Trygg, J. Data integration in plant biology: The O2PLS method for combined modelling of transcript and metabolite data Plant J. 2007, 52, 1181-91
43. Lachenbruch, P. A. An almost unbiased method of obtaining confidence intervals for the probability of misclassification in discriminant analysis Biometrics 1967, 23, 639-645
44. Merrifield, C. A.; Lewis, M.; Claus, S. P.; Beckonert, O. P.; Dumas, M. E.; Duncker, S. A metabolic system-wide characterization of the pig: A model for human physiology Mol. BioSyst. 2011, 7, 2577-2588
45. Ranjan, P.; Gupta, A.; Kumar, S.; Nagana, G. G. A.; Ranjan, A.; Sonkar, A. A. Detection of new amino acid marker of liver injury by proton nuclear magnetic resonance spectroscopy Liver Int. 2006, 26, 703-707
46. 1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure NMR Biomed. 2006, 19, 521-526
47. Gupta, A.; Mahdi, A. A.; Shukla, K. K.; Ahmad, M. K.; Bansal, N.; Sankhwar, P.; Sankhwar, S. N. Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: A proton NMR study at 800 MHz J. Ethnopharmacol. 2013, 149, 208-214
48. Subramanium, A.; Gupta, A.; Saxena, S.; Gupta, A.; Kumar, R.; Nigam, A.; Kumar, R.; Roy, R. Proton MR CSF analysis and new software as predictors for the differentiation of meningitis in children NMR Biomed. 2005, 18, 213-225
49. Sugino, T.; Baba, K.; Hoshi, N.; Aikawa, K.; Yamaguchi, O.; Suzuki, T. Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients Med. Mol. Morphol. 2011, 44, 146-150
50. McClinton, S.; Moffat, L. E. F.; Horrobin, D. F.; Manku, M. S. Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer Br. J. Cancer. 1991, 63, 314-316
51. McGarry, J. D.; Mannaerts, G. P.; Foster, D. W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis J. Clin. Invest. 1977, 60, 265-270
52. Dill, A. L.; Ifa, D. R.; Manicke, N. E.; Costa, A. B.; Ramosa-Vara, J. A.; Knapp, D. W.; Cooks, R. G. Lipid profiles of canine invasive transitional cell carcinoma of the urinary bladder and adjacent normal tissue by desorption electrospray ionization imaging mass spectrometry Anal. Chem. 2009, 81, 8758-8764
53. Ralph, S. J.; Rodríguez-Enríquez, S.; Neuzil, J.; Moreno-Sánchez, R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger Mol. Aspects Med. 2010, 31, 29-59
54. Echtay, K. S.; Murphy, M. P.; Smith, R. A.; Talbot, D. A.; Brand, M. D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants J. Biol. Chem. 2002, 277, 47129-47135
55. Echtay, K. S.; Roussel, D.; St-Pierre, J.; Jekabsons, M. B.; Cadenas, S.; Stuart, J. A. Superoxide activates mitochondrial uncoupling proteins Nature 2002, 415, 96-99
56. Fernandez-Gomez, F. J.; Galindo, M. F.; Gómez-Lázaro, M.; Yuste, V. J.; Comella, J. X.; Aguirre, N.; Jordán, J. Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathway Br. J. Pharmacol. 2005, 144, 528-537
57. Mirandola, S. R.; Melo, D. R.; Schuck, P. F.; Ferreira, G. C.; Wajner, M.; Castilho, R. F. Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake J. Inherited Metab. Dis. 2008, 31, 44-54
58. Bianchi, L.; Micheli, E. D.; Bricolo, A.; Ballini, C.; Fattori, M.; Venturi, C.; Pedeta, F.; Tipton, K. F.; Corte, L. D. Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study Neurochem. Res. 2004, 29, 325-334
59. Tisdale, M. J. Cancer cachexia: Metabolic alterations and clinical manifestations Nutrition 1997, 13, 1-7
60. Dang, C. V. Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells Cell Cycle 2010, 9, 3884-3889
61. Tripathi, P.; Somashekar, B. S.; Ponnusamy, M.; Gursky, A.; Dailey, S.; Kunju, O. HR-MASS NMR tissue metabolomic signatures cross-validated by mass spectrometry distinguish bladder cancer from benign disease J. Proteome Res. 2013, 12, 3519-3528
62. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biol. Med. 2010, 49, 1603-1616
63. Klein, R. D.; Pelt, C. S. V.; Sabichi, A. L.; Cerda, J. D.; Fischer, S. M.; Furstenberger, G. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression Cancer Res. 2005, 65, 1808-1813
64. Serel, T. A.; Soyupek, S.; Candir, O. Association between mast cells and bladder carcinoma Urol. Int. 2004, 72, 299-302
65. Haak-Frendscho, M.; Darvas, Z.; Hegyesi, H.; Karpati, S.; Hoffman, R. L. Histidine decarboxylase expression in human melanoma J. Invest. Dermatol. 2000, 115, 345-352
66. Graff, L.; Frungieri, M.; Zanner, R.; Pohlinger, A.; Prinz, C.; Gratzl, M. Expression of histidine decarboxylase and synthesis of histamine by human small cell lung carcinoma Am. J. Pathol. 2002, 160, 1561-1565
67. Putluri, N.; Shojaie, A.; Vasu, V. T.; Vareed, S. K.; Nalluri, S. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression Cancer Res. 2011, 71, 7376-86
68. Lopez-Beltran, A.; Cheng, L. Stage pT1 bladder carcinoma: Diagnostic criteria, pitfalls and prognostic significance Pathology 2003, 35, 484-491